 BASKING RIDGE, N.J., Nov. 07, 2022 GLOBE NEWSWIRE -- Lisata Therapeutics, Inc. Nasdaq: LSTA Lisata or the Company, a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that management will participate in the following events: 